STROKE F-MISO: Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke

Sponsor
University Hospital, Toulouse (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01866189
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France (Other)
0
1
30

Study Details

Study Description

Brief Summary

This study is a French multicenter prospective study including 5 stroke units with available MRI and F-MISO PET for patients with acute ischemic stroke.

Background and Purpose: 18F-Fluoromisonidazole (FMISO) PET has been used to identify hypoxic tissues in animals and stroke patients. While MRI has become the gold standard acute stroke imaging, no published study has compared FMISO PET and MRI.

The aim of this prospective study is to identify hypoxic tissues in 40 patients with acute ischemic stroke with F-MISO PET and to compare the location and the outcome of these hypoxic cells with MRI datas (weighted diffusion and FLAIR) and to clinical outcome.

Condition or Disease Intervention/Treatment Phase
  • Other: PET and MRI
N/A

Detailed Description

40 prospective patients (aged 18 to 85 years) will be included in the first 36 hours after ischemic stroke onset.

The study period will be 2 years. Included patients will have F-MISO PET followed by brain MRI (MRI-1)(diffusion, FLAIR, perfusion, TOF) as soon as possible after stroke onset (less than 36 hours). A second brain MRI (MRI-2) will be performed on day 7.

The aim of the study is to locate hypoxic tissues and to compare with ischemic tissues defined by diffusion and FLAIR MRI sequences, with MRI evolution, and with clinical status at day 7 and day 90.

Inclusion criterias

  • Patients aged 18-85 years with encephalic brain ischemic stroke,

  • defined stroke onset,

  • NIHSS 5 to 20,

  • F-MISO Pet and MRI available <36 hours after stroke onset,

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Assessment of Hypoxic Tissues in Acute Ischemic Stroke With 18F-FMISOnidazole PET and Comparison With MRI : A Prospective Multicenter Study
Study Start Date :
Sep 1, 2016
Anticipated Primary Completion Date :
Sep 1, 2016
Anticipated Study Completion Date :
Oct 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: PET and MRI

Included patients will have F-MISO PET followed by brain MRI (MRI-1)(diffusion, FLAIR, perfusion, TOF) as soon as possible after stroke onset (less than 36 hours). A second brain MRI (MRI-2) will be performed on day 7.

Other: PET and MRI
F-MISO PET followed by brain MRI (MRI-1)(diffusion, FLAIR, perfusion, TOF)
Other Names:
  • TEP
  • Outcome Measures

    Primary Outcome Measures

    1. volume and location of F-MISO uptake in stroke patients [acute phase of brain ischemia < 36 hours]

    Secondary Outcome Measures

    1. comparison of F-MISO uptake areas and ischemic lesions defined by weighted diffusion and FLAIR on [acute phase of brain ischemia < 36 hours]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients aged 18-85 years with encephalic brain ischemic stroke,

    • defined stroke onset,

    • NIHSS 5 to 20,

    • F-MISO Pet and MRI available <36 hours after stroke onset,

    • Written consent signed by patient or family

    Exclusion Criteria:
    • contraindication to MRI

    • comatous status

    • 5 < NIHSS > 20

    • non ischemic stroke

    • brainstem stroke

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University Hospital, Toulouse
    • Institut National de la Santé Et de la Recherche Médicale, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Toulouse
    ClinicalTrials.gov Identifier:
    NCT01866189
    Other Study ID Numbers:
    • 11 252 01
    First Posted:
    May 31, 2013
    Last Update Posted:
    May 9, 2016
    Last Verified:
    May 1, 2016

    Study Results

    No Results Posted as of May 9, 2016